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A B S T R A C T
After the introduction of catheter intervention for atrial septal defect (ASD) in the pediatric population,
therapeutic advantagesof this less invasiveprocedurewere focusedonadult throughgeriatric populations.
The most valuable clinical beneﬁts of this procedure are the signiﬁcant improvement of symptoms and
daily activities, which result from the closure of left to right shunt without thoracotomy and
cardiopulmonary bypass surgery. These beneﬁts contribute to increase the number of adult patients of
this condition who have hesitated over surgical closure. In terms of technical point of view for catheter
closureofASD, thedifﬁculties still exist in somemorphological featuresof defect, orhemodynamic features
in the adult population. Morphological features of difﬁcult ASD closure are (1) large (30 mm) ASD, (2)
wide rim deﬁciency, and (3) multiple defects. Hemodynamic features of difﬁcult ASD are (1) severe
pulmonary hypertension, (2) ventricular dysfunction, and (3) restrictive left ventricular compliance
(diastolic dysfunction) after ASD closure. To complete the catheter ASD closure under these difﬁcult
conditions, variousprocedural techniqueshavebeen introduced. Thesearenew imagingmodalities suchas
real-time three-dimensional imaging, new technical modiﬁcations, and new concepts for hemodynamic
evaluation. Especially, real-time three-dimensional transesophageal echocardiography can provide the
high quality imaging for anatomical evaluation including maximum defect size, surrounding rim
morphology, and the relationship between device and septal rim. In adult patients, optimal management
for their comorbidities is an important issue, which includes cardiac function, atrial arrhythmias,
respiratory function, and renal function.Management of atrial arrhythmias is a key issue for the long-term
outcome inadult patients.Because the interventional procedures arenot complication-free techniques, the
establishment of a surgical back-up system is essential for the safe achievement of the procedure. Finally,
the establishment of a team approach including pediatric and adult cardiologists, cardiac surgeons, and
anesthesiologists is the most important factor for a good therapeutic outcome.
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Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Clinical feature of ASD in various aged populations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Transcatheter closure of ASD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Morphological features of difﬁcult transcatheter ASD closure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Cardiac erosion and its mechanism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Imaging modality for transcatheter ASD closure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Various closure techniques for difﬁcult ASD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Hemodynamic features of difﬁcult transcatheter ASD closure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Pulmonary arterial hypertension and ASD. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Speciﬁc issues for management of elderly patients with ASD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Future direction of transcatheter intervention for ASD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25* Correspondence to: Cardiac Intensive Care Unit, Okayama University Hospital, 2-5-1, Shikata-cho, Okayama, Okayama 700-8558, Japan. Tel.: +81 86 235 7357;
fax: +81 86 235 7683.
E-mail address: t-akagi@cc.okayama-u.ac.jp
http://dx.doi.org/10.1016/j.jjcc.2014.09.002
0914-5087/ 2014 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.
[(Fig._2)TD$FIG]
2%
23%
11%
8%
23%
11%
17%
5%
Trigger of ASD diagnosis 
heart murmur
 symptoms
arrhythmia
heart failure
examinaon
cerebral infarcon cerebral abscess 
pulmonary embolism 
other  disease
 unknown
Fig. 2. Trigger of diagnosis of adult patients with atrial septal defect (ASD) age older
than 40 years. Symptoms (palpitation, shortness of breath, etc.) and routine
physical examination are the most common factors for trigger of diagnosis.
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Atrial septal defect (ASD) accounts for 7% of all congenital heart
diseases. The most common ASD is a secundum defect, versus
defects located in the septum primum, sinus venosus defects, or
unroofed coronary sinus [1]. If left untreated, these defects may
result in right-sided heart failure, arrhythmia, and pulmonary
hypertension. Although surgical closure of ASD is safe, effective, and
time-tested, it requires open heart surgery and hospitalization
[2]. Even in the current surgical procedure, complicationswhich are
related to surgery or cardiopulmonary bypass havenot disappeared.
Clinical feature of ASD in various aged populations
Clinical features of ASD are widely varied from pediatric
population through adults [3–6]. Themajority of these children are
asymptomatic and diagnosed by school physical examination,
heart murmur detected by primary care pediatrician, and cardiac
echocardiographic screening in the newborn period. If the defect is
smaller than 6 mm, spontaneous closure can be expected during
newborn to pediatric periods [7]. Operation is scheduled based on
children’s body size, usually before the elementary schoolwith low
incidence of mortality rate. On the contrary, adult patients with
ASD are usually symptomatic. Their heart disease may be
discovered as a result of palpitation, arrhythmia, or progress of
congestive heart failure. In our recent series of adult patients with
ASD, they were diagnosed within 3 years before the procedure,
meaning that themajority of adult patients could not be diagnosed
during the pediatric period under the current medical screening
system (Fig. 1) (unpublished data). In 1990Murphy and colleagues
reported the natural course of ASD [2]. In this study, survival rate
was signiﬁcantly deteriorated compared to the general population,
if patients did not have surgical closure until age of 24 years and/or
therewere complicationswith pulmonary hypertension. However,
our current patients’ backgrounds are signiﬁcantly different
compared to such studies, rather numerous adult patients are
asymptomatic and occasionally diagnosed at the time of detailed
cardiovascular evaluation for atrial arrhythmia, congestive heart
failure, or stroke (Fig. 2).
Although the catheter closure of pediatric or young adults with
ASD population has attracted research interest over the past two
decades, that of the elderly ASD population has yet to be
characterized [8]. Extrapolation of studies on younger patients is
not appropriate in the geriatric patients. First, elder patients with
ASDacquire comorbid conditions includearrhythmia, hypertension,
respiratory distress, kidney disease, etc. that always play a[(Fig._1)TD$FIG]72%
12%
16%
Interval from Diagnosis to Intervenon
within 3 years
within 3 5 years
over 5years
Fig. 1. Interval from the diagnosis of atrial septal defect to intervention in adult
patients age older than 40 years. More than 80% of patients were diagnosed within
5 years before the intervention.signiﬁcant role in their heart conditions [4,9]. Second, elder ASD
patients may have inherently superior resilience, milder disease, or
balanced physiology in contrast to those not surviving to an
advanced age. Therefore, elder or geriatric patients with ASD
represent a distinct population for which focused studies are
needed.
Transcatheter closure of ASD
Transcatheter closure of ASD is associated with low complica-
tion rates, short anesthetic times, and short hospitalizations
[5]. When conditions are favorable, transcatheter ASD closure has
become the treatment of choice rather than surgery in many
institutions. Echocardiography, either transesophageal (TEE) or
intracardiac, plays a signiﬁcant role in the guidance of these
procedures and in the assessment of the ﬁnal result. Research
efforts are ongoing to examine other imaging modalities, such as
computed tomography (CT) or magnetic resonance imaging (MRI),
as a means of three-dimensional (3D) imaging prior to transcath-
eter ASD closure. To date, Amplatzer Septal Occluder (St. Jude
Medical, St. Paul, MN, USA) is widely used in the world. This device
is suitable for all subtypes of ASD and has successfully closed
defects as large as 38 mm in diameter. Much larger sized devices
are available, such as Occlutech device (Helsingborg, Sweden) [10]
or Lifetech Cera devices (Shenzhen, China) [11]. However,
procedural difﬁculties still exist due to morphological features
of septal defect or from a hemodynamic stand point.
Morphological features of difﬁcult transcatheter ASD closure
It is well known that morphological variations of ASD are
frequent and appropriate patient selection for transcatheter ASD
closure is crucial for successful procedure. ASDs are grouped into
four major categories: ostium primum, ostium secundum, sinus
venosus, and coronary sinus septal defect. Secundum defect is the
most commontypeofASDs inwhich thedefect involves the regionof
fossa ovale, and this type is indicated for transcatheter ASD closure.
Coronary sinus septal defect is a rare type, in which a communica-
tionoccursbetweenthecoronary sinus and the left atriumasa result
of unroofed coronary sinus. Primum septal defect and sinus venosus
defect are indicated for surgical repair. Regarding coronary sinus
septal defect, although surgical repair is the standard treatment for
this type of ASD, there are some case reports in which transcatheter
closure was successful without any conduction disturbance [12].
In patients with secundum septal defect, two crucial param-
eters, which are the maximal ASD diameter in order to select a
device with the appropriate size and the surrounding rim
dimensions to optimize the placement of the device, should be
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diameter must be less than 38 mm. Most ASDs have ellipsoidal
shape and that varies during cardiac cycle. Themajor axis diameter
of the defect measured in the phase of ventricular end systole is
mandatory for selecting the optimal device size, especially in
patients undergoing the procedure without balloon sizing or
multiple defects. Transcatheter closure of large ASD with a
maximal native diameter >30 mm is challenging, and alternative
special techniques for deployment of the device are usually
required. In regard to classiﬁcation of surrounding rims, although
there are some differences among studies, distances from ASD to
aorta (superoanterior rim), superior vena cava (superoposterior
rim), right upper pulmonary vein (posterior rim), inferior vena
cava (inferoposterior rim), coronary sinus, and atrioventricular
valve (inferoanterior rim) are assessed. The deﬁnition of rim
deﬁciency varies among different studies; any rim was considered
deﬁcient if its length was <5 mm.
Cardiac erosion and its mechanism
In patients with superoanterior rim deﬁciency, the risk of
serious complication, so-called ‘‘cardiac erosion’’ may increase
after the device implantation. Although the deﬁnite mechanism of
‘‘cardiac erosion’’ has not been established completely, previous
clinical experience suggested that an aortic rim deﬁciency and
oversized occlusion device may be highly related with cardiac
erosion [13]. However, a large number of cases with an aortic rim
[(Fig._3)TD$FIG]
Fig. 3. Speculation of mechanism of cardiac erosion in patients having atrial septal m
alignment. (b) Illustration of ASD with atrial septal malalignment. Impinging of the righ
atrium; PA, pulmonary artery; RV, right ventricle; LV, left ventricle; LCC, left coronarydeﬁciency resulted in a successful deployment without compli-
cating cardiac erosion. Morphological factors additional to an
aortic rim deﬁciency should be considered in cases with cardiac
erosion.
Atrial septal malalignment is a morphological characteristic
frequently encountered in cases with a deﬁcient aortic rim.
Surfaces arising from septum primum and septum secundum are
different in a defect with malaligned atrial septum resulting in
vertical displacement and tight impingement of the right atrial
disk toward the right atrium. As the device is deployed against the
atrial septum from the left atrium side, the right atriumdiskmoved
toward to the left atrium side after the release. Atrial septal
malalignment causes a change in the device axis angle against the
aortic root andmay be a risk for cardiac erosion in catheter closure
of ASD using Amplatzer Septal Occluder (Fig. 3). Although
observation of both sides of the disks before and after the release
of the device is important, assessment of this situation before the
device deployment is difﬁcult. Device deployment against an ASD
complicated with a deﬁcient aortic rim can result in a splay of the
disks across the aortic root with impingement of the device. Atrial
septal malalignment can swell the tight impingement of the
device, especially after releasing the cable. Thus, atrial septal
malalignment may be a potential risk factor for cardiac erosion
[14].
Recently, the instruction for user (IFU) of Amplatzer Septal
Occluder has been updated especially for avoiding cardiac erosion
[15]. That is, the contraindication for defect margins less thanalalignment. (a) Illustration of atrial septal defect (ASD) with normal atrial septal
t atrial disk on the right atrium toward the aortic root is indicated (arrow). LA, left
cusp; RCC, right coronary cusp; RA, right atrium.
T. Akagi / Journal of Cardiology 65 (2015) 17–25205 mm has been updated to include the inferior vena cava rim,
because such defect characters tend to be caused by oversized
device selection.
Imaging modality for transcatheter ASD closure
Two-dimensional (2D) and color Doppler transthoracic echo-
cardiography (TTE) can demonstrate the presence of ASDs,
chamber dilatation, estimated pulmonary artery pressure, shunt
ratio, and other coexisting heart disease with high sensitivity and
speciﬁcity in real time. And the advent of tissue Doppler imaging
could facilitate understanding of cardiac diastolic function in
which impaired cardiac function before ASD closure may lead to
development of congestive heart failure after ASD closure
especially in elderly patients [4,16,17]. However, in terms of
accurate assessment of ASD morphology including measurements
of maximal diameter and surrounding rims, 2D TTE has sometimes
limited ability to visualize ASDs in detail clearly especially in adult
patients; thus precise evaluation using TEE is necessary in most
ASD patients [18,19].
3D echocardiography provides better spatial visualization and
3D TEE can delineate the 3D structurewith high-resolution images.
As the result, 3D echocardiography offers the ability to improve
display and our understanding of complex lesions such as valvular
and congenital heart disease [19–24]. In addition, although 3D
echocardiography was initially based on reconstructed images
from serial 2D images, which required cumbersome acquisition
and time-consuming ofﬂine analysis, recently real-time 3D
echocardiography using matrix array transducer has been
available in TTE as well as TEE. 3D TTE is a promising modality
to provide comprehensible en face image of ASD because of its
noninvasiveness, low cost, portability, and wide availability
(Fig. 4). In terms of patient selection for transcatheter ASD closure,
3D TTE has a potential to provide accurate information of ASD
morphology including location, size, and surrounding rims for
treatment both in children and adults. However, there are several
limitations to 3D TTE at present such as dependence on the skill of[(Fig._4)TD$FIG]Fig. 4. Three-dimensional (3D) imaging of large elliptical shape atrial septal defect. 3D im
atrium; RA, right atrium.the operator, restrictive echo window especially in elderly
patients, echo dropout in the region of the mid portion which
can lead to false diagnoses of large defects, and lower both
temporal and spatial resolutions compared to 2D TTE. On the other
hand, ASDmorphology can be recognizedwith high-quality en face
image using 3D TEE. Real-time 3D TEE allows for evaluation of
various shapes of ASD especially in patients with complex-shaped
ASDs such as multiple ASDs (Fig. 5) [19,22,23].
Various closure techniques for difﬁcult ASD
Various technicalmodiﬁcationswere reported for transcatheter
ASD closure. These included the modiﬁcation of delivery sheath,
deployment position, or additional material to hold the left atrial
disk inside the left atrium, avoiding the left atrial disk slipping into
the right atrial side.
Rotation of the delivery sheath within the heart, or increasing
the curvature of the sheath by remolding outside the body has
been described to improve alignment [25]. Some have advocated
deployment of the left atrial disk in the right or left upper
pulmonary vein followed by pulling of the sheath into the right
atrium to improve the approach to the atrial septum in large
defects [26] (Figs. 6 and 7). Concerns exist with this technique
causing injury of the pulmonary vein. A specially designed sheath
(Hausdorf sheath, Cook, Bloomington, IN, USA) can be used to help
align the left atrial disk parallel to the atrial septum [26–
28]. Favorable changes in the approach to the interatrial septum
and increased ability to deliver the device have been reported with
the Hausdorf sheath [29]. Kutty and colleagues developed a
method to modify a Mullins transseptal sheath to enhance
delivery. The resulting sheath is straight and has an exit oriﬁce
essential in the side of the distal portion of the sheath-a straight,
side-hole delivery sheath [30]. Use of a balloon catheter [31] or a
long dilator [32] to support the left atrial disk and prevent its
prolapse into the right atrium during deployment has been
described. Although this technique requires additional venous
access, the procedure, especially balloon assist technique, isaging provides easy and accurate detection of maximum diameter of defect. LA, left
[(Fig._5)TD$FIG]
Fig. 5. Catheter closure of multiple atrial septal defects (ASDs). (a) Three-dimensional (3D)-transesophageal echocardiography imaging shows two isolated defects, large
defect was 24 mm and small defect was 7 mm. (b) Balloon sizing was performed simultaneously on both defects. (c) 28-mm and 10-mm devices were deployed. (d) 3D
imaging after the ASD closure deployed two devices.
[(Fig._6)TD$FIG]
Fig. 6. Left upper pulmonary vein technique. (a) Left atrial disk was deployed inside the left upper pulmonary vein. (b) Both sides of disk of 38-mm device were opened in
optimal position. (c) 38-mm device was successfully deployed.
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Fig. 7. Right upper pulmonary vein technique. (a) Long sheath was approached inside the right upper pulmonary vein. (b) Left atrial disk of 32-mm device was opened just
beneath right upper pulmonary vein. (c) Both sides of disk were successfully deployed. In this case, pulmonary artery pressure was continuously monitored during the
deployment.
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high procedure success can be expected. Operators are not
required to be familiarized with all of these techniques, however,
operators should master one or two of different techniques to
achieve procedure success for difﬁcult patients or defect anatomy.
Hemodynamic features of difﬁcult transcatheter ASD closure
Pulmonary arterial hypertension and ASD
Not only morphologically, hemodynamic features inﬂuence
difﬁculties of transcatheter ASD closure. Candidates for ASD
closure have a hemodynamically signiﬁcant atrial shunt or the
presence of right ventricular volume overload, and/or clinical
symptoms of dyspnea, reduced exercise capacity, or paradoxical
embolism. Pulmonary vascular resistance <5 Wood units/m2 and
the peak pulmonary artery pressure 70% of the systemic blood
pressure are also important conditions for ASD closure. Although
most pediatric patients with ASD fulﬁll the hemodynamic criteria,
the incidence of pulmonary artery hypertension is signiﬁcantly
increased in adult populations. It is well known that the natural
course in patients with ASD and pulmonary hypertension is
signiﬁcantly worse than in patients without pulmonary hyperten-
sion [2]. Thus, closure of ASD in patients with pulmonary
hypertension was considered as a high-risk procedure, especially
with surgical closure [9]. However, transcatheter closure without
cardiopulmonary bypass can be performed even in such high-risk
patients, and several clinical studies have demonstrated the
efﬁcacy and safety of ASD closure [33,34]. Importantly, the moresigniﬁcant reduction of pulmonary artery pressure can be achieved
even in severe pulmonary hypertension. Furthermore, the expan-
sion of therapeutic indications is considered under the combina-
tion of new pulmonary hypertension-speciﬁc medical treatment,
such as prostanoids, endothelin receptor antagonists, and phos-
phodiesterase-5 inhibitors. Even if the initial hemodynamic
parameter appears to be untreatable (or contraindicated) for
ASD closure, catheter closure of ASD may be performed if such
pulmonary vascular resistance can be considered as responder for
pulmonary artery speciﬁc vasodilators [35]. Long-term follow-up
is mandatory especially in these high-risk populations (Fig. 9).
Speciﬁc issues for management of elderly patients with ASD
In the past, surgical correction of ASD in the geriatric population
has not been indicated positively, because of difﬁculties of
perioperative management and a high incidence of comorbidities.
Additionally, geriatric patients by themselves did not wish open
heart surgery, even if hemodynamic beneﬁt could be expected.
However, after the introduction of the transcatheter closure of
ASD, the experiences of older or geriatric patients are signiﬁcantly
increasing [4,17,33].
In the elderly patients with ASD, hemodynamic features are
signiﬁcantly different from those in children and young adults.
Elderly patients with ASD frequently present with hemodynamic
abnormalities such as pulmonary hypertension, atrial arrhythmias,
and valvular regurgitation, which causes congestive heart failure
[4,16,17]. As the incidence of pulmonary hypertension signiﬁcant-
ly increases with age in ASD patients, the decision of ASD closure is
[(Fig._8)TD$FIG]
Fig. 8. Balloon assist technique. (a) Under the assist of partial inﬂation of Amplatzer sizing balloon, left atrial disk of 34-mm device was opened inside the left atrium. (b)
Subsequently, right atrial disk was opened inside the right atrium. (c) Sizing balloonwas gradually deﬂated. (d) Sizing balloonwas completely deﬂated. (e) Sizing balloon and
guidewire were retrieved. (f) 34-mm device was successfully deployed.
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hypertension. Moreover, various comorbidities, such as systemic
hypertension, chronic obstructive pulmonary disease, coronary
artery disease, chronic kidney disease, and left ventricular diastolic
dysfunction often complicate the clinical features in this popula-
tion. Left ventricular diastolic dysfunction, which is also seen as
part of normal aging and frequently occurs in elderly individuals
with hypertension or increased arterial stiffness, may cause acute
congestive heart failure after ASD closure [16].
In our institution, approximately 10% of cases of transcatheter
closure of ASD were patients aged older than 70 years. Most of
these patients had at least one major comorbidity, including
systemic hypertension, stroke, coronary artery disease, and atrialﬁbrillation. More than half of the patients were being treated with
a diuretic for congestive heart failure, and 30% of the patients had a
history of hospitalization due to heart failure. The majority of
patients had symptoms of heart failure classiﬁed as New York
Heart Association (NYHA) functional class more than II [4].
Previous studies have suggested that development of acute
congestive heart failure is due to abrupt elevation in left
ventricular preload following transcatheter ASD closure, especially
in elderly patients with impaired left ventricular systolic or
diastolic function [8,16]. In our experience, despite the fact that our
patients had impaired left ventricular diastolic function estimated
by decreased e0 and increased E/e0 as well as various comorbidities,
acute congestive heart failure after the ASD closure has not
[(Fig._9)TD$FIG]
Fig. 9. Change of pulmonary arterial pressure in patients with atrial septal defect
(ASD) and pulmonary hypertension (PH). Solid lines demonstrate the patients who
were treated with PH-speciﬁc medication (advanced medical group: AM group).
Dashed lines demonstrate patients who were treated with normal medication
(diuretics: NM group). After catheter closure of ASD, further improvement of PH
was conﬁrmed.
[(Fig._10)TD$FIG]
Fig. 10. Catheter closure in an 82-year-old patient with large atrial septal defect and
permanent atrial ﬁbrillation. (a) Pulmonary capillary wedge pressure (PCW) was
continuously monitored during the device deployment. (b) 32-mm device was
deployed and no signiﬁcant elevation of PCW pressure was observed.
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ongestive medication was important and effective for preventing
congestive heart failure after ASD closure in elderly patients
[4]. Additionally, we routinely monitored pulmonary capillary
wedge pressure (PCWP) during the procedure to avoid the acute
congestive heart failure caused by ASD closure in elderly patients.
If mean PCWP increased > 10 mmHg from the baseline value
during balloon occlusion of the defect (test balloon occlusion), or
PCWP increased>20 mmHg, we judge such ASD closure could lead
to the development of pulmonary edema and the procedure should
be abandoned (Fig. 10). Especially in patients who had a history of
heart failure, we considered to be hemodynamically high-risk
patients. Creation of a fenestration hall in the device may avoid the
abrupt hemodynamic change after the transcatheter closure of
ASD. However, the optimal fenestration size has not been
evaluated, and the experiences are still limited [36].
Although the majority of elder patients were complicated with
various comorbidities, a high procedural success rate can be
expected even in this aged population. Also, signiﬁcant improve-
ment in NYHA functional class was observed after closure even
though about 30% of the patients in this study had a history of
hospitalization for congestive heart failure. No patient required
additional hospitalization for congestive heart failure during the
follow-up period.
Atrial arrhythmias are the most commonly seen comorbidities
in adult patients with ASD. In our experience, approximately one
third of patients aged over 60 years, or half of patients aged over
70 years, are complicated with atrial ﬁbrillations. Previously, we
reported the clinical beneﬁts of catheter closure of ASD in patients
with permanent atrial ﬁbrillation [37]. Even in patients compli-
cated with atrial ﬁbrillation, the resolution of left to right shunt
contributes signiﬁcant improvement of clinical symptoms of these
patients. Although, strict anticoagulation treatment is required
even after the ASD closure, transcatheter closure of ASD should be
considered even in patients with permanent atrial ﬁbrillation
without age limitation (Fig. 10). In patients complicated with
symptomatic paroxysmal or persistent atrial ﬁbrillation, catheter
ablation such as pulmonary vein isolation should be indicated prior
to the catheter closure of ASD. In our institution, pulmonary vein
isolation is indicated in patients aged younger than 75 years,
symptomatic paroxysmal or persisted atrial arrhythmias, and left
atrial dimension <50 mm. Transcatheter ASD closure is scheduled
when sinus rhythm persists >3 months after the ablation.
Although the experiences are still limited, the collaborationsbetween electrophysiological and interventional procedures can
contribute to new therapeutic strategies in patients with ASD and
atrial arrhythmias.
Future direction of transcatheter intervention for ASD
Transcatheter closure of ASD using currently available devices
has been established as safe and effective medical treatment for
most patients with ASD. Although some speciﬁc anatomical
features are not suitable for this procedure, the remaining patients
are probably treatable by cardiac surgery. On the other side,
complications due to this procedure, especially cardiac erosion, are
still observed in a certain number patients. The mechanism of
cardiac erosion has not been clariﬁed completely, some erosion
occurred even in the long-term after the procedure. Thus,
longitudinal follow-up after this procedure is essential. Other
important concerns, such as device-induced late atrial arrhyth-
mias, atrioventricular valve regurgitation, and reaction of myocar-
dial tissue should be checked in the future.
The target of this procedure has been expanded from the
pediatric population to adults, including the geriatric population.
In this regard, the collaboration between adult and pediatric
cardiologists has to be conducted as total therapeuticmanagement
T. Akagi / Journal of Cardiology 65 (2015) 17–25 25in this procedure. If possible, the establishment of an adult
congenital heart disease specialist in each institution, which
involved these interventional procedures, is the most desirable
direction for optimal patient care.
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